TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies.

Jean Francois Timsit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.